Immunreconstitution and Infectious Complications After Rituximab Treatment in Children and Adolescents: What Do We Know and What Can We Learn from Adults?
Author:
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
http://www.mdpi.com/2072-6694/7/1/305/pdf
Reference100 articles.
1. Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
2. Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death
3. Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics
4. Mechanisms of action of CD20 antibodies;Boross;Am. J. Cancer Res.,2012
5. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development;Clinical Immunology;2023-12
2. B cell subsets reconstitution and immunoglobulin levels in children and adolescents with B non-Hodgkin lymphoma after treatment with single anti CD20 agent dose included in chemotherapeutic protocols: single center experience and review of the literature;Biomedical Papers;2023-05-23
3. Analysis the immunoglobulin level in high risk pediatric Burkitt’s lymphoma treated with intensive chemotherapy combined with different doses of rituximab in real world;2023-03-13
4. Acquired B-cell deficiency secondary to B-cell-depleting therapies;Journal of Immunological Methods;2022-12
5. Hypogammaglobulinemia in Children After Hematopoietic Stem Cell Transplantation and Rituximab Treatment: Relevance of B Cell Subsets;Journal of Pediatric Hematology/Oncology;2022-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3